Results 191 to 200 of about 7,125 (253)

Breaking Free From MCHC Interferences? French-Speaking Cellular Haematology Group (GFHC) Review of Causes, Rising Trends and Practical Solutions. [PDF]

Int J Lab Hematol
Girard S, Berda-Haddad Y, Brouzes C, Badaoui B, Boussaroque A, Janel A, Chatelain B, Baccini V.   +7 more
europepmc   +1 more source

A Novel Approach to Prognostic Factors and Risk Stratification in Pediatric AML: Case Report and Literature Review. [PDF]

Int J Mol Sci
Leśniak M, Sekunda A, Kamizela E, Deleszkiewicz P, Ozygała A, Zawitkowska J, Lejman M.   +6 more
europepmc   +1 more source

Cases of Septic Arthritis During Meningitis Infection at Zinder National Hospital, Niger Republic. [PDF]

Int Med Case Rep J
Doutchi M, Lagare A, Adoum Fils S, Mahaman Moustapha L, Adamou Bara AA, Abraham GT, Yacouba A, Hamsatou B, Sahada MS, Abdoul Aziz G, Ousmane S, Faye M.   +11 more
europepmc   +1 more source

Hydroxyurea for Malignant Pertussis in Critically Ill Children. [PDF]

Crit Care Explor
Blanc M, Marais C, Debs A, Cousin VL, Tissières P, Paris Saclay Neonatal and Pediatric ICU Research Alliance (PANDORA) Study Group.   +5 more
europepmc   +1 more source

Response to: Correspondence on "Hyperleukocytosis in a neuroblastoma patient after treatment with natural killer T cells expressing a GD2-specific chimeric antigen receptor and IL-15" by Ataca Atilla and Atilla. [PDF]

J Immunother Cancer
Tian G, Courtney AN, Heczey A, Metelitsa LS.   +3 more
europepmc   +1 more source

Atypical hyperlymphocytosis following CAR T-cell infusion.

Blood
Vossen CJ, Collie AMB.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hyperleukocytosis and leukostasis in acute and chronic leukemias

Leukemia and Lymphoma, 2022
Leukostasis is a life-threatening complication of high concentrations of circulating leukemic cells, most often myeloblasts. Effective care of patients with leukostasis involves early recognition and treatment, and aggressive management of concurrent ...
Walid Macaron, Nicholas J Short
exaly   +2 more sources

Chronic Myeloid Leukemia with Hyperleukocytosis.

New England Journal of Medicine
Bashir Bashir
semanticscholar   +3 more sources

Lipegfilgrastim may cause hyperleukocytosis

Journal of Oncology Pharmacy Practice, 2022
Introduction Granulocyte colony-stimulating factors (G-CSF) are utilized both in the treatment and prophylaxis of chemotherapy-induced neutropenia. Lipegfilgrastim is a long-acting G-CSF. Albeit it provides ease of administration compared to short-acting GCSFs, some lipegfilgrastim-related adverse events may occur.
Zekeriya Hannarici, Ali Yılmaz, Mehmet Emin Buyukbayram, Aykut Turhan, Salim Başol Tekin, Mehmet Bilici   +5 more
openaire   +3 more sources